SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-20-001792
Filing Date
2020-02-14
Accepted
2020-02-14 16:14:38
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 saenger-form5_123119.html 5  
1 saenger-form5_123119.xml 5 5115
  Complete submission text file 0001387131-20-001792.txt   6598
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
SAENGER BRADLEY (Reporting) CIK: 0001668150 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36019 | Film No.: 20619970